Kane William P Jr 4
4 · BioXcel Therapeutics, Inc. · Filed Aug 18, 2021
Insider Transaction Report
Form 4
Kane William P Jr
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-16+40,000→ 40,000 totalExercise: $23.84Exp: 2031-08-16→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of August 16, 2021 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person'scontinuous employment with the Issuer through the relevant vesting dates.